title: Gamma butyrolactone (GBL) withdrawal syndromes.
authors.affiliation: Psychiatry Service, James A. Haley Veterans' Hospital, Tampa, FL, USA. gcatalan@hsc.usf.edu
authors.forename: M C
authors.initials: MC
authors.lastname: Catalano
authors.forename: J M
authors.initials: JM
authors.lastname: Glass
authors.forename: G
authors.initials: G
authors.lastname: Catalano
authors.forename: S L
authors.initials: SL
authors.lastname: Burrows
authors.forename: W A
authors.initials: WA
authors.lastname: Lynn
authors.forename: B S
authors.initials: BS
authors.lastname: Weitzner
mesh_terms: D015107:4-Butyrolactone / Q000009:adverse effects*; D000328:Adult; D003702:Delusions / Q000139:chemically induced; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D013375:Substance Withdrawal Syndrome; D014891:Weight Lifting
chemical_list: D015107:4-Butyrolactone